In conclusion, due to the existence of hypoxic microenvironment in BLCA, cisplatin chemotherapy exacerbates the hypoxic state, resulting in co‐activation of STAT5A and HIF‐1α on PGK1. The gene discussed is HIF1A; the disease is bladder transitional cell carcinoma.